Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-19

Clinical Trial Update: Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating intravenous iron supplementation for remission in celiac disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Celiac Disease | Phase 4 | Status: UNKNOWN